Clinical Trials Browser

Phase 2 × Drug Therapy × Plasma cell × Clear all

NCT01531751 2018-03-21

DIACAL

Phase 2 Withdrawn

Immunoglobulin Light-chain Amyloidosis

NCT00112879 2013-07-10

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell